Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT05011045
Recruiting
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Not applicable · United States · 1 site
Registry update: 20 May 2026
NCT04077307
Recruiting
A Study in Leukemia Patients With Karonudib
Phase 1 · Denmark, Serbia, Sweden · 7 sites
Registry update: 6 Aug 2026
NCT03909412
Recruiting
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Phase 1 · United States · 1 site
Registry update: 21 Sept 2026
NCT03937635
Recruiting
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Puerto Rico, United States · 748 sites
Registry update: 19 Aug 2026
NCT04068597
Recruiting
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/2 · Spain, France, United Kingdom, Sweden, United States · 39 sites
Registry update: 24 Jun 2026
NCT03711110
Recruiting
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
Not applicable · Spain · 14 sites
Registry update: 21 Mar 2025
NCT04025450
Recruiting
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
Phase 1/2 · China · 1 site
Registry update: 19 Jul 2019
NCT04162353
Recruiting
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Phase 1 · China · 2 sites
Registry update: 16 Sept 2025
NCT04115241
Recruiting
Activity Levels in Bone Marrow Transplant Patients
Not applicable · United States · 1 site
Registry update: 10 Nov 2025
NCT04114084
Recruiting
Sleep Apnea in Patients With MGUS and MM
Not applicable · United States · 1 site
Registry update: 10 Nov 2025
NCT04271644
Recruiting
BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
Phase 1/2 · China · 1 site
Registry update: 25 Feb 2025
NCT03858205
Recruiting
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Not applicable · United States · 9 sites
Registry update: 5 Jun 2026
NCT03966443
Recruiting
Fluciclovine PET/CT in Multiple Myeloma Patients
Not applicable · Norway · 1 site
Registry update: 30 May 2019
NCT03823534
Recruiting
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Phase 3 · United States · 1 site
Registry update: 22 Apr 2026
NCT03807128
Recruiting
MYeloma Resistance And Clonal Evolution
Not applicable · France · 2 sites
Registry update: 14 Jul 2025
NCT03852407
Recruiting
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
Phase 2 · Belgium · 9 sites
Registry update: 12 Oct 2022
NCT03761108
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/2 · Belgium, Germany, Spain, United Kingdom, Japan, South Korea, United States · 40 sites
Registry update: 26 Oct 2026
NCT03412877
Recruiting
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Phase 2 · United States · 1 site
Registry update: 30 Oct 2026
NCT03616483
Recruiting
The Indiana Myeloma Registry
Not applicable · United States · 1 site
Registry update: 29 Oct 2026
NCT03314974
Recruiting
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · United States · 1 site
Registry update: 25 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.